=#%%%%#+.
:#%%%%%%%%%-
#%%%%%%%%%%%-
.%%%%%%%%%%%%%=
*%%%%%%%%%%%%%+
.*%%%%%%%%%%%%%+.
.#%%%%%%%%%%%%%*
.*%%%%%%%%%%%%%#.
.#%%%%%%%%%%%%%#.
#%%%%%%%%%%%%%%.
.:-. .#%%%%%%%%%%%%%#:
:#%%%%%%%- :%%%%%%%%%%%%%%%:
+%%%%%%%%%%#- =%%%%%%%%%%%%%%%%-
-%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%=
-%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%+
.#%%%%%%%%%%%%+-:..:-*%%%%%%%%%%%%%%%%+
*%%%%%%%%#: -#%%%%%%%%%%%%%%*.
.:+##*-. =%%%%%%%%%%%%%%*
=%%%%%%%%%%%%%%#.
:%%%%%%%%%%%%%%#.
.+#%%%%%*: .=#%%%%%#- -%%%%%%%%%%%%%%%:
=%%%%%%%%%%*. .+%%%%%%%%%%#. .#%%%%%%%%%%%%%#:
-%%%%%%%%%%%%%#+=::-+#%%%%%%%%%%%%%# .#%%%%%%%%%%%%%%-
*%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%#. #%%%%%%%%%%%%%#.
-%%%%%%%%%%%%%%#-..:*%%%%%%%%%%%%%%# .*%%%%%%%%%%%%#.
=%%%%%%%%%%*: .+%%%%%%%%%%#. *%%%%%%%%%%#:
.*#%%%%%#: .*#%%%%%#: -#%%%%%%#+.
.... .... ..::..
Scaling Scientific Interpretation
Modern science is no longer limited by measurement. It is limited by interpretation.
Explore ProjectsAcross biology, chemistry, physics, and materials science, experimental systems generate data at extraordinary scale. Mass spectrometers, sequencers, imaging systems, and high-throughput platforms produce vast volumes of structured signal describing the physical world.
Yet the rate at which we convert those signals into understanding remains constrained by human bandwidth. Expert analysts spend weeks manually identifying compounds, cross-referencing databases, and validating results.
The bottleneck in modern science is not data acquisition. It is structured interpretation at scale.
We build AI models that learn directly from raw experimental data—mass spectrometry, sequencing, imaging. Instead of relying on manual analysis and limited databases, our models understand the underlying patterns in scientific measurements.
What takes expert analysts weeks now takes hours.
Our systems identify compounds, predict structures, and validate results automatically. They integrate into existing lab workflows, work across different instruments and conditions, and improve as they process more data.
Our first focus is pharmaceutical R&D and contract research organizations (CROs). These labs generate massive amounts of mass spectrometry data but spend weeks manually identifying compounds and validating results.
We're running pilot programs with CROs to prove our models work in real workflows.
Small, focused pilots. Concrete metrics: time saved, accuracy improved, analyst effort reduced. API integration into existing systems. No workflow disruption.
This work is research-intensive and infrastructure-heavy. It requires compute scale, careful evaluation design, and long-horizon thinking.
Drug discovery is too slow. Materials research is too expensive. Scientific progress is bottlenecked by our ability to understand the data we already have.
AI can change this—but only if it's built for science, not retrofitted from consumer applications.
We're building the infrastructure that pharmaceutical companies, research labs, and CROs need to move faster. Our models integrate into existing workflows, work with real data, and deliver measurable results.
Faster interpretation means faster discovery. Faster discovery means better outcomes.
Learn more about our approach, technology, and current projects.